COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

Dr. Lawrence Ng

Dr. Lawrence Ng

Scientific Review Officer


Division of Translational and Clinical Sciences DTCS
Oncology 2 – Translational Clinical OTC
Study Section:
Cancer Biomarkers CBSS

Dr. Lawrence Ng serves as the Scientific Review Officer for CSR’s Cancer Biomarkers Study Section.

Dr. Ng received his Ph.D. and post-doctoral training in pharmaceutical sciences from the University of Wisconsin at Madison and the University of Kansas. Prior to coming to NIH, Dr. Ng was an associate professor and the principal investigator and co-investigator of several NIH grant awards (R01 and R21) at the University of Colorado Health Sciences Center and the National University of Singapore, where he spearheaded drug delivery research and discovery and elucidation of mechanism of anti-cancer agents derived from natural products.